Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Key Opinion Leader (KOL) in Pharmaceutical Business Intelligence – Aviva Lev-Ari, PhD, RN, as Evidenced by

Curator: Aviva Lev-Ari, PhD, RN

Updated on 7/30/2026

The Founder’s Radar Screen rests on a documented foundation of Key Opinion Leader (KOL) status established for Aviva Lev-Ari, PhD, RN as early as 2016 and continuously expanded thereafter. The July 21, 2016 article “Key Opinion Leader (KOL) in Pharmaceutical Business Intelligence – Aviva Lev-Ari, PhD, RN, as Evidenced by” (updated 2022) systematically records the measurable markers of that status: authorship and curation of multiple BioMed e-Books, top-ranked article views on pharmaceuticalintelligence.com (hundreds of thousands of individual views and over one million site readers by mid-2016, later growing to multi-million scale), real-time press coverage of dozens of major biotech and medical conferences, management of specialized LinkedIn groups, and a high-seniority network of thousands of first-degree connections concentrated in biotech and pharma.

These same disciplined practices of continuous scanning, expert curation, and synthesis—originally applied to pharmaceutical business intelligence, genomics, oncology, and cardiovascular science—have evolved directly into the present-day Founder’s Radar Screen. In its current form the Radar Screen functions as a structured, ongoing barometer of the competitive ecosystem of AI in Health corporations and industry segments, operating in deliberate parallel to Alex Wissner-Gross’s daily technology and frontier-AI intelligence (The Innermost Loop) and to Demis Hassabis’s strategic interventions on AI in life sciences and scientific discovery.

The historical KOL evidence therefore supplies independent validation that the Radar Screen is not an ad-hoc collection of links but the continuation of a 14-year, domain-expert curation methodology that has already demonstrated scale, consistency, and recognized authority.

 

 

UPDATED on 4/4/2022

Analytics for e-Reputation based on LinkedIn 1st Degree Connections, +7,500 of LPBI Group’s Founder, 2012-2022: An Intangible Asset – Connections’ Position Seniority & Biotech / Pharma Focus

Author: Aviva Lev-Ari, PhD, RN, Founder of 1.0 LPBI, 2012-2020 & 2.0 LPBI, 2021-2025 and Data Scientist, Research Assistant III: Tianzuo George Li

https://pharmaceuticalintelligence.com/2022/04/04/analytics-for-e-reputation-based-on-linkedin-1st-degree-connections-7500-of-lpbi-groups-founder-2012-2022-an-intangible-asset-connections-position-seniority-biotech-pharma-focus/

 

• e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point

• Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018

WE ARE ON AMAZON.COM – 1/1/2018 – 13 e-Books in Medicine and Life Sciences

https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Ddigital-text&field-keywords=Aviva+Lev-Ari&rh=n%3A133140011%2Ck%3AAviva+Lev-Ari

https://www.amazon.com/s/ref=dp_byline_sr_ebooks_9?ie=UTF8&text=Aviva+Lev-Ari&search-alias=digital-text&field-author=Aviva+Lev-Ari&sort=relevancerank

 

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

http://www.amazon.com/dp/B071VQ6YYK

https://www.amazon.com/dp/B075CXHY1B

https://www.amazon.com/dp/B076HGB6MZ

https://www.amazon.com/dp/B078313281

https://www.amazon.com/dp/B078QVDV2W

 

FIVE years of e-Scientific Publishing @pharmaceuticalintellicence.com, Top Articles by Author and by e-Views >1,000, 4/27/2012 to 1/29/2018

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2017/04/28/five-years-of-e-scientific-publishing-pharmaceuticalintellicence-com-top-articles-by-author-and-by-e-views-1000-4272012-to-4272017/

 

Top Authors, by +5 years of e-Views, 1/29/2018, on pharmaceuticalintelligence.com

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2017/04/25/top-authors-by-5-years-of-e-views-4252017-on-pharmaceuticalintelligence-com/

 

Digital Presence measured by eViews:  Clicks on articles by Author Name

Top Authors for all days ending 2018-05-28 (Summarized)

1. Our 15 e-Books in Genomics and Medicine were on Display at the Publication Desk of CHI @CHI’s 14th Annual Discovery on Target took place September 19 – 22, 2016 in Boston, Westin Boston Waterfront

https://pharmaceuticalintelligence.com/2016/09/17/our-15-e-books-in-genomics-and-medicine-on-display-at-the-publication-desk-of/

2. New e-Book TITLES forthcoming on Amazon.com in 2018 from LPBI Group’s BioMed e-Series

• Volume Five:Pharmacological Agents in Treatment of Cardiovascular Diseases

Work-in-Progress

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-five-pharmaco-therapies-for-cvd/

• Volume Six: Interventional Cardiology and Cardiac Surgery for Disease Diagnosis and Guidance of Treatment

Work-in-Progress

https://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-six-interventional-cardiology-and-cardiac-surgery/

• Genomics Volume 2: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology

Work-in-Progress

https://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-two-genomics-methodologies-ngs-bioinformatics-simulations-and-the-genome-ontology/

3. June 19, 2016 – We Celebrate reaching over One Million e-Readers @PharmaceuticalIntelligence.com

https://pharmaceuticalintelligence.com/2016/06/19/june-19-2016-we-celebrate-reaching-over-one-million-e-readers-pharmaceuticalintelligence-com/

4. Founder

https://pharmaceuticalintelligence.com/founder/

5. Editorial & Publication of Articles in e-Books by Leaders in Pharmaceutical Business Intelligence: Contributions of Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2014/10/16/editorial-publication-of-articles-in-e-books-by-leaders-in-pharmaceutical-business-intelligence-contributions-of-aviva-lev-ari-phd-rn/

6. Corporate Clients for our Services: Funding Medical Devices Development & Biologics

https://pharmaceuticalintelligence.com/joint-ventures/corporate-clients-for-our-services/

7. REAL TIME Press Coverage for Biotech and Medicine, Scientific and Business Investment International Conferences

List of Conferences Covered in Real Time by

Aviva Lev-Ari, PhD, RN on Press Pass, 2013 – Present

Year	# Conferences covered in Real Time	Conference Organizers
2020
2019
2018	10	MassBio, AI,ML&CL, MassBio-Devices&Drugs, WMIF-AI-Partners, US-India BioPharma, BioIT, BIO 2018!, Koch@MIT, , CHI-DiscoveryonTarget, PMC-HMS
2017	12	MassBio, WMIF-CVD-Partners, US-India BioPharma, BioIT, Koch@MIT, CHI-IO CHI OncoVirus IO, WarrenLecture-HMS, HubWeek, Koch@MIT, EmTech@MIT, PMC-HMS
2016	8	MassBio, WMIF-Cancer-Partners, US-IndiaBioPharma, CHI-IO, CHI-OncoVirus IO, CHI DiscoveryonTarget, EmTech @MIT, PMC-HMS
2015	5	PMWC-SiliconVallley, MassBio, BioIT, EmTech@MIT, PMC-HMS,
2014	7	SacksAssoc-NY, MassBio, BioIT Koch@MIT, SacksAssoc-Basel, Brandeis, PMC-HMS,
2013	1	BioIT

https://pharmaceuticalintelligence.com/press-coverage/

8. Social Media Influence and Channels for Content e-Marketing 

• Our Journal has 1,436,050 eReaders, 2,339 subscribers and 7,291 Scientific Comments on 28/5/2018, for All Time, 28/4/2012 – 28/5/2018

http://pharmaceuticalintelligence.com

• Aviva has +6,592 BIOTECH Followers on LinkedIn

http://www.linkedin.com/in/avivalevari

• Aviva is a Member of +60 LinkedIn Groups in Biotech-related fields

https://www.linkedin.com/groups/my-groups

• LPBI Group’s FaceBook Page

http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence

• LPBI Group’s Twitter Account with hundreds of followers

http://twitter.com/pharma_BI

• Aviva is a LinkedIn (LI) Group Launcher and Manager of Three LI Groups
  

  Cardiovascular Biotech & Pharma UK & US Networking Group

  918 members (1/2018)

  Leaders in Pharmaceutical Business Intelligence

  344 members (1/2018)

  Innovation in Israel

  191 members (1/2018)

• LPBI Group’s Company’s Page on LinkedIn

https://www.linkedin.com/company/9325543?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A9325543%2Cidx%3A1-1-1%2CtarId%3A1439226813927%2Ctas%3ALeaders%20in%20Pharmaceutica

Additional LINKS on Professional Activities as Parameters of the Key Opinion Leader

• Scientific and Medical Affairs Chronological CV

• HealthCare Delivery – Long Term Post Acute Care Nursing Management CV

• Editorial & Publication of Articles in e-Books by Leaders in Pharmaceutical Business Intelligence

• List of Publications, 2006 – Present

• Cardiovascular Diseases and Pharmacological Therapy: Curations, 2006 – 4/2018

• MedTech & Medical Devices for Cardiovascular Repair – Curations

• Stem Cells and Cardiac Repair: Content Curation & Scientific Reporting

• Regulatory Affairs: Publications on FDA-related Issues – Aviva Lev-Ari, PhD, RN

• Cancer Research: Curations and Reporting